FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to new oxytocin analogues, pharmaceutical compositions containing them, using these compounds in preparing a drug for treating lactation disorders particularly. The compounds are presented by general formula 
as additionally specified in the description.
EFFECT: preparing the new oxytocin analogues.
16 cl, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| OXYTOCIN RECEPTOR AGONISTS | 2010 |
|
RU2539692C2 |
| PEPTIDE COMPOUNDS | 2007 |
|
RU2415149C2 |
| NOVEL METHODS OF PRODUCING BARUSIBAN AND INTERMEDIATE COMPOUNDS THEREOF | 2016 |
|
RU2726414C2 |
| METHOD FOR PRODUCING PEPTIDE EXENATIDE | 2011 |
|
RU2458066C1 |
| V1A-RECEPTORS AGONISTS | 2013 |
|
RU2634617C2 |
| SYNTHETIC PEPTIDES REDUCING OR ELIMINATING BAGGY LOWER EYELIDS, AND APPLICATION THEREOF IN COSMETIC OR DERMOPHARMACEUTICAL COMPOSITIONS | 2005 |
|
RU2387666C2 |
| METHOD FOR SITE-SPECIFIC PEGYLATION | 2007 |
|
RU2424246C2 |
| METHOD FOR PRODUCING PEPTIDES CONTAINING LIPOPHILICALLY MODIFIED LYSINE SIDE CHAIN | 2017 |
|
RU2755543C2 |
| INHIBITORS OF VIIA FACTOR | 1999 |
|
RU2223967C2 |
| PRODRUG CONTAINING A SELF-CLEAVABLE LINKER | 2018 |
|
RU2798085C2 |
